Skip to main content
Allison O'Neill, MD, Pediatric Hematology & Oncology, Boston, MA

AllisonO'NeillMD

Pediatric Hematology & Oncology Boston, MA

Instructor, Dana-Farber Cancer Institute

Dr. O'Neill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. O'Neill's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215
    Phone+1 617-632-4202

Education & Training

  • Boston Children’s Hospital/Boston Medical Center
    Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2005 - 2008
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2005

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2019
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Screening with Whole-Body Magnetic Resonance Imaging in Pediatric Subjects with Li–Fraumeni Syndrome: A Single Institution Pilot Study  
    Judy E Garber, Lisa Diller, Junne Kamihara, Allison F O'Neill, Pediatric Blood & Cancer

Lectures

  • Alfa-feto protein (AFP) as a predictor of outcome for children with germ cell tumors: A report from the malignant germ cell international consortium. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Eureka Therapeutics Announces Initiation of Phase I/II ARYA-2 Clinical Trial of ET140203 ARTEMIS® T Cells to Treat Pediatric Liver Cancer
    Eureka Therapeutics Announces Initiation of Phase I/II ARYA-2 Clinical Trial of ET140203 ARTEMIS® T Cells to Treat Pediatric Liver CancerNovember 17th, 2021
  • Count Me in Launches New Project for Pediatric Hepatocellular Carcinoma (PediHCC) and HCC-like Tumors
    Count Me in Launches New Project for Pediatric Hepatocellular Carcinoma (PediHCC) and HCC-like TumorsDecember 8th, 2023